PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home » Special Reports

Psychiatric Times. Vol. 29 No. 9
A LITERATURE REVIEW 

The Role of Gender in Disease Expression: A Literature Review

By Editorial Staff | September 6, 2012

Gender differences in obsessive-compulsive disorder: a literature review

de Mathis MA, de Alvarenga P, Funaro G, et al. Rev Bras Psiquiatr. 2011;33:390-399.

(MORE: Neuropsychiatric Differences Between Boys and Girls With ADHD)

OCD is made up of heterogeneous subtypes—one such is gender, which plays a relevant role in phenotypic expression. In this literature review, the researchers looked at 63 studies to determine the gender differences in clinical, genetic, and familial aspects of OCD. They found that males were more likely to be sin-gle; to present with an early onset and chronic course; and to have greater social impairment, more sexual-religious and aggressive symptoms, and greater comorbidity with tic and substance use disorders. Females had more contamination/cleaning symptoms and greater comorbidity with eating and impulse control disorders. Although the studies are inconclusive, they suggest that gender plays a role in disease expression of OCD.

Premenstrual dysphoric disorder: evidence for a new category for DSM-5

Epperson CN, Steiner M, Hartlage SA, et al. Am J Psychiatry.2012;169:465-475.

Premenstrual dysphoric disorder was included in Appendix B of DSM-IV as “Criterion Sets and Axes Provided for Further Study.” A task force of experts has now been convened by the Mood Disorders Work Group for DSM-5 to review the literature on premenstrual dysphoric disorder and provide recommendations regarding the disorder for DSM-5. After lengthy discussions and evaluation of the data, the 8-member task force has proposed the inclusion of premenstrual dysphoric disorder as a full category in DSM-5. Its inclusion will benefit the minority of women who experience significant monthly distress by encouraging evidence-based research that will, in turn, provide better treatment modalities and thus better outcomes.

Gender differences in white matter microstructure

Kanaan RA, Allin M, Picchioni M, et al. PLoS One. 2012;7:e38272.

Diffusion tensor imaging was used to determine gender differences in white matter microstructure. Analysis of findings showed high levels of dimorphism between the brains of men and women: men had higher fractional anisotropy (FA) in cerebellar white matter and in the left superior longitudinal fasciculus; women had higher FA in the corpus callosum. The differences were substantial, which suggests that gender may be a potentially significant confounder. Higher FA may represent more “efficient” white matter organization.

Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys

Seedat S, Scott KM, Angermeyer MC, et al. Arch Gen Psychiatry.2009;66:785-795.

The decrease in gender differences in anxiety and externalizing disorders has led to interest in the “gender roles” hypothesis. This hypothesis posits that as the role of women improves, the differences narrow. Seedat and colleagues undertook a time-space variation study of mental disorders based on cohorts from the WHO World Mental Health Survey Initiative, which was a survey of community-dwelling adults in Africa, the Americas, Asia, Europe, the Middle East, and the Pacific. They found that gender differences in anxiety, mood, externalizing, and substance disorders remained relatively stable despite the changes in female gender role over time. However, the findings suggest that in more recent cohorts, there were significant gender differences in major depression, intermittent explosive disorder, and substance disorders.

Women and psychosis

Seeman MV. Womens Health (Lond Engl). 2012;8:215-224.

Seeman reviews the evidence for gender differences in the presentation of psychosis. She finds subtle differences in several areas, which have important treatment implications. Mental health programs that address the different needs of the two sexes are required. In particular, the mother-child dyad presents unique challenges, and services that provide targeted care for mothers with schizophrenia are crucial—the mother’s health will impact the health of her child.

An investigation of whether there are sex differences in certain behavioural and neurochemical parameters in the rat

Simpson J, Kelly JP. Behav Brain Res. 2012;229:289-300.

In this report of preclinical study results, Simpson and Kelly review the effects of gender on depression- and anxiety-like symptoms, learning and memory, and stress response in rats, as well as sexual dimorphisms in monoamine neurotransmitter and neurotrophic factor levels, neurogenesis and plasticity, and responsiveness to drugs of abuse. Compared with male rats, female rats had greater baseline activity levels and also responded more actively in conditioning paradigms, but they were somewhat impaired in tests of spatial memory. Depending on the nature of the stressor, female and male rats had different responses on baseline and stress-induced hypothalamic-pituitary-adrenal measures. Differences were also seen in the response to psychotropics, which may be due to differences in neurotransmitter activity and transporter and receptor expression. The impact of the estrous cycle on behavior, neurochemistry, dendritic growth, and drug response was determined using ovariectomized and intact female rats. Study data from both male and female rats can be translated to gender differences in humans and used to identify potential treatment strategies.

The influence of sex-linked genetic mechanisms on attention and impulsivity

Trent S, Davies W. Biol Psychol. 2012;89:1-13.

There are inherent gender differences across neurobiological domains such as brain structure, neurochemistry, and cognition. Evidence also shows gender differences in prevalence, clinical features/progression, neurobiology, and pathology of disorders. Trent and Davies discuss the mechanisms that underlie gender differences. They also consider to what extent these differences affect attention and impulsivity and the role that gender plays in modulating disorders such as ADHD, autism, and addiction. Identifying novel sex-modulated molecular targets may help in the development of more effective therapies for attentional/impulsive disorders.

Psychopathy in women: theoretical and clinical perspectives

Wynn R, Høiseth MH, Pettersen G. Int J Womens Health. 2012;4:257-263.

Research has primarily been focused on psychopathy in men. Thus the question remains of whether psychopathy exists in women and, if so, how does it manifest itself. The authors review the literature on gender and psychopathy and consider the causes of psychopathy and the importance for women. Diagnostic tools, such as the Hare Psychology Checklist–Revised, are examined to gauge their effectiveness on the basis of gender. The similarities as well as the differences between the sexes are discussed as well as prevalence, behavioral expressions, comorbidity, progression, and treatment.

 

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Arne N. Gjorgov | October 20, 2012 10:00 AM EDT

To the Editorial Staff,
Psychiatric Times
Message box
September 20, 2012

Re: The role of gender in disease expression: A literature review, by Editorial Staff, Psychiatric Times, September 6, 2012. Comments

Dear Sirs:

I have been investigating for a long while in the field of breast cancer, primary prevention and a new approach to the etiology of the disease, and woman's health, I would like to join the discussion about some aspects of gender disease expression.

The basic evidence of the initial hypothesis-testing study was the corroboration of the hypothesis and demonstration of evidence that condomization of female sexuality is significantly associated with the development of breast cancer in American and other (married) women. The inferences (the conclusions, deductions) stemming from the evidence were manifold, among which at least two perhaps deserve mentioning. The first inference points out to the high likelihood that marriage along with sex, love and family, is a profound biological woman-man union, with tremendous physiological impact, which seems complementary to the conventional definition of marriage as a psychological, social, economic and legal unit. The second inference, perhaps worth mentioning is the perception that the root cause of breast cancer as an epidemic disease is due to the elimination, reduction or absence of certain putative protective factors in the intimate (sexual) woman-man relations and micro-environment (rather than pouring chemical / toxin contaminants), and barriers installed in the primordial reproductive biosystem.

Breast cancer is a predominant sex- (gender-) specificity in disease development, rather than (unprovoked) expression of morbidity in females. In my view, the biggest gender confounding and bias is the 'unisex' analysis related to most somatic and mental diseases, medical history and tumors in women. In addition, it is still not fully known what the biological impact, if at all is, in today women who reduced their fertility from ≥8 parity to ±2 childbirths in the past two generations. Alone or in (biological) tandem with man. More in: "AIDS Changed America with the Twin Breast Cancer Epidemic: Exploring the Consequences of Condomization."(Ch. 22). Editor: Nancy Dumais, InTech Publ., Vienna, Austria, Oct. 2011. Web:
http://www.intechopen.com/articles/show/title/aids-changed-america-with-the-twin-breast-cancer-epidemic-exploring-the-consequences-of-condomizatio

The premenstrual dysphoric disorder is perhaps the initial sign of a variety of the 'controversial' syndrome of female sexual disorders (FSDs), which include amenorrhea, pain, depression…More about it in: "Condomization of female sexuality - The Cause of FSD (Female Sexual Dysfunction)." British Medical Journal-Online: http://bmj.com/cgi/eleters/326/7379/45#29155 , Jan 26, 2003.

The experimental laboratory study, "Efficacy of preventive prostaglandin treatment of malignant mammary lesions in rats. An experimental trial" (Gjorgov AN, Junaid TA, Burns GR, Temmim L.) in J Balkan Union of Oncology (J-BUON), Athens. 1999; 4: 295-306, tested a different approach to specific 'stressor' in female rats, to male sterility. Namely, prevention of mammary neoplasia was created in environment resembling human one, without any chemical, physical, radiological or nutritional exposure, but to sterility, both male and female, in six groups and a control group. The efficacy of prostaglandin preventive treatment against breast carcinomas showed to be present in more than 73% of cases. Abstract: Eur J Cancer Prev (London) 1996; 5 (Suppl 2): 104. Webs:
http://journals.lww.com/eurjcancerprev/Citation/1996/12002/Efficacy_of_Preventive_Prostaglandin_Treatment_of.21.aspx ; and http://www.unet.com.mk/medics/mammay.html

Based on the research evidence, it is my belief that the prevention of and protection against the prevalent so-called 'psychopathy' and 'comorbidity' in women of all ages is more feasible and possible to be carried out, rather than to consider treatments only for the future. More in: "Anorexia and Bulimia Nervosa in Young Female Patients and Barrier Contraception Practice." ASKLEPIOS, International Annual of History and Philosophy of Medicine (Sofia) 2009; Vol. III New series (Vol. XXII Old series): pp. 97-108.

Besides the current, excess breast cancer epidemic and the rampant anorexia-bulimia ('eating') disorders as prevalent sex- (gender-) specific comorbidities in women (mothers) and girls (dauthers), the contraception is to primarily protect the health and life of woman herself. The evidence indicates that both perplexing epidemics in women of all ages reflect the misconceptions and misunderstood biology of intimate micro-environment and primordial reproductive biosystem of woman-man relations, of the reproductive health and female sexual needs, resulting in diseases in women's life. It seems that what has been missed, applied wrongly to (condomization), or ignored during the adolescent and reproductive life-span accumulates as a late or belated expression, such as the osteoporosis or various malignancies during menopause. More in: "Reproductive health of women: An attempt to define breast cancer prevention." Mac J Med Sci, 2010 June 15,3(2):169-79.
http://www.mjms.ukim.edu.mk/Online/MJMS_2010_3_2/MJMS.1857-5773.2010-0104v.pdf

I'll appreciate if you could convey my communication in the discussion to your wider audience.

Arne N. Gjorgov, M.D., Ph.D. (UNC-SPH, Chapel Hill, NC)
Author of "Barrier Contraception and Breast Cancer," 1980: x+164

Sept, Oct 2012 SR on Gender Differences

Working With Transgender Persons

The Role of Gender in Disease Expression: A Literature Review

How Gender Plays a Role in Disease Expression

Eating Disorders in Males

Neuropsychiatric Differences Between Boys and Girls With ADHD






 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Developmental Psychopathology Comes of Age
  • Grief and Depression: The Sages Knew the Difference
  • The Moral Struggles of Practicing Psychiatrists
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Developmental Psychopathology Comes of Age
  • Psychiatry and the Myth of “Medicalization”
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Journey of the Traumatized Hero: Kerouac’s On the Road and Gandhi’s Railroad Ride
  • DSM-5: Where Do We Go From Here?
  • Suicidal Behavior: A Separate Diagnosis
  • New Insight Into the Neurobiology of Depression
  • Cultural Psychiatry and the 'No-Chicken' Doctor
  • Benefits of CAM Therapies for Dementia
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • Diagnosis and its Discontents: The DSM Debate Continues
  • Lamotrigine for Major Depressive Disorder Is Inappropriate
  • Psychiatry and the Myth of “Medicalization”
  • Parity Laws: Powerful Weapon—or Pipe Dream?
  • The Moral Struggles of Practicing Psychiatrists
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • NIMH vs DSM 5: No One Wins, Patients Lose
Click here to subscribe to our newsletter

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy